Hetacillin in a single dose in the treatment of gonorrhoeae
Autor(a) principal: | |
---|---|
Data de Publicação: | 1971 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista de Saúde Pública |
Texto Completo: | https://www.revistas.usp.br/rsp/article/view/4597 |
Resumo: | Schemes of treatment with one single parenteral injection or single oral dosis of a broad spectrum antibiotic - Hetacillin - has been employed in 155 patients with acute gonorrhoeae who were, then, followed-up during 15 days in the Service of VD of the School of Public Health, University of São Paulo. The diagnosis and control of the cases were performed through smears and cultures of the urethral discharge. Cure has been attained in 88,6% of 70 patients treated with 3.0 g of Hetacillin by oral route, in a single dosis, and in 93% of 85 patients treated with one single intramuscular injection of Hetacillin (1.0 g). Discharge has disappeared in an average of 48 hours in both schedules of treatment. No side effects or toxicity were observed. |
id |
USP-23_6d309559510d7992a22c4cf977523317 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/4597 |
network_acronym_str |
USP-23 |
network_name_str |
Revista de Saúde Pública |
repository_id_str |
|
spelling |
Hetacillin in a single dose in the treatment of gonorrhoeae Hetacilina em dose única no tratamento da gonorréia HetacilinaGonorréiaAntibióticosHetacillinGonorrhoeaeAntibiotics Schemes of treatment with one single parenteral injection or single oral dosis of a broad spectrum antibiotic - Hetacillin - has been employed in 155 patients with acute gonorrhoeae who were, then, followed-up during 15 days in the Service of VD of the School of Public Health, University of São Paulo. The diagnosis and control of the cases were performed through smears and cultures of the urethral discharge. Cure has been attained in 88,6% of 70 patients treated with 3.0 g of Hetacillin by oral route, in a single dosis, and in 93% of 85 patients treated with one single intramuscular injection of Hetacillin (1.0 g). Discharge has disappeared in an average of 48 hours in both schedules of treatment. No side effects or toxicity were observed. Foram tratados 155 pacientes do sexo masculino, portadores de uretrite gonocócica aguda, com 3,0 g de Hetacilina K por via oral (70 casos) ou 1,0 g do mesmo medicamento por via intramuscular (85 casos). Em 88,6% dos casos tratados pela via oral, e em 93% dos casos tratados com uma injeção intramuscular, o corrimento desapareceu em um tempo médio de 48 horas. Não foram observadas reações de intolerância ao medicamento. Universidade de São Paulo. Faculdade de Saúde Pública1971-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/rsp/article/view/459710.1590/S0034-89101971000100005Revista de Saúde Pública; Vol. 5 No. 1 (1971); 47-50 Revista de Saúde Pública; Vol. 5 Núm. 1 (1971); 47-50 Revista de Saúde Pública; v. 5 n. 1 (1971); 47-50 1518-87870034-8910reponame:Revista de Saúde Públicainstname:Universidade de São Paulo (USP)instacron:USPporhttps://www.revistas.usp.br/rsp/article/view/4597/6126Copyright (c) 2017 Revista de Saúde Públicainfo:eu-repo/semantics/openAccessBarros, J. Martins deMenezes, Jairo P. de2012-04-27T19:01:02Zoai:revistas.usp.br:article/4597Revistahttps://www.revistas.usp.br/rsp/indexONGhttps://www.revistas.usp.br/rsp/oairevsp@org.usp.br||revsp1@usp.br1518-87870034-8910opendoar:2012-04-27T19:01:02Revista de Saúde Pública - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Hetacillin in a single dose in the treatment of gonorrhoeae Hetacilina em dose única no tratamento da gonorréia |
title |
Hetacillin in a single dose in the treatment of gonorrhoeae |
spellingShingle |
Hetacillin in a single dose in the treatment of gonorrhoeae Barros, J. Martins de Hetacilina Gonorréia Antibióticos Hetacillin Gonorrhoeae Antibiotics |
title_short |
Hetacillin in a single dose in the treatment of gonorrhoeae |
title_full |
Hetacillin in a single dose in the treatment of gonorrhoeae |
title_fullStr |
Hetacillin in a single dose in the treatment of gonorrhoeae |
title_full_unstemmed |
Hetacillin in a single dose in the treatment of gonorrhoeae |
title_sort |
Hetacillin in a single dose in the treatment of gonorrhoeae |
author |
Barros, J. Martins de |
author_facet |
Barros, J. Martins de Menezes, Jairo P. de |
author_role |
author |
author2 |
Menezes, Jairo P. de |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Barros, J. Martins de Menezes, Jairo P. de |
dc.subject.por.fl_str_mv |
Hetacilina Gonorréia Antibióticos Hetacillin Gonorrhoeae Antibiotics |
topic |
Hetacilina Gonorréia Antibióticos Hetacillin Gonorrhoeae Antibiotics |
description |
Schemes of treatment with one single parenteral injection or single oral dosis of a broad spectrum antibiotic - Hetacillin - has been employed in 155 patients with acute gonorrhoeae who were, then, followed-up during 15 days in the Service of VD of the School of Public Health, University of São Paulo. The diagnosis and control of the cases were performed through smears and cultures of the urethral discharge. Cure has been attained in 88,6% of 70 patients treated with 3.0 g of Hetacillin by oral route, in a single dosis, and in 93% of 85 patients treated with one single intramuscular injection of Hetacillin (1.0 g). Discharge has disappeared in an average of 48 hours in both schedules of treatment. No side effects or toxicity were observed. |
publishDate |
1971 |
dc.date.none.fl_str_mv |
1971-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/4597 10.1590/S0034-89101971000100005 |
url |
https://www.revistas.usp.br/rsp/article/view/4597 |
identifier_str_mv |
10.1590/S0034-89101971000100005 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/rsp/article/view/4597/6126 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2017 Revista de Saúde Pública info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2017 Revista de Saúde Pública |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Saúde Pública |
dc.source.none.fl_str_mv |
Revista de Saúde Pública; Vol. 5 No. 1 (1971); 47-50 Revista de Saúde Pública; Vol. 5 Núm. 1 (1971); 47-50 Revista de Saúde Pública; v. 5 n. 1 (1971); 47-50 1518-8787 0034-8910 reponame:Revista de Saúde Pública instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Revista de Saúde Pública |
collection |
Revista de Saúde Pública |
repository.name.fl_str_mv |
Revista de Saúde Pública - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
revsp@org.usp.br||revsp1@usp.br |
_version_ |
1800221767686422528 |